Global Hospital Infection Therapeutics Market Analysis, Trends and Insights 2018- 2023
Summary - A new market study, titled “Global Hospital Infection Therapeutics Market 2018 by Manufacturers, Countries, Type and Application, Forecast to 2023 ” has been featured on WiseGuyReports.
Hospital-acquired
infections, also known as nosocomial infections, are acquired by patients in
the hospitals or healthcare facilities. Urinary tract infections, bloodstream
infections, surgical-site infections, Clostridium difficile associated
diarrhea, and pneumonia are examples of nosocomial infections
This report studies the Hospital Infection Therapeutics market
status and outlook of Global and major regions, from angles of players,
countries, product types and end industries; this report analyzes the top
players in global market, and splits the Hospital Infection Therapeutics market
by product type and applications/end industries.
The hospital infection therapeutics market is increasing at a significant rate,
due to high susceptibility of neonatal population in healthcare setting and
high occurrence of numerous hospital infections. Increasing incidences of
hospital infections, high number of pipeline drug molecules for specific
treatment of healthcare associated infections and high unaddressed needs in
most of the countries are some of the factors providing ample opportunities for
the hospital infection therapeutics market to grow in the coming years.
North America led the demand for hospital infection therapeutics market in
2017. The high prevalence of nosocomial infections has been identified as the
key factor that has been driving the demand for infection therapeutics in North
America and is projected to continue to do so throughout the forecast period.
Although North America will remain the leading regional market for hospital
infection therapeutics, it is Asia Pacific, which will present the most
promising growth opportunities to this market in the near future.
The global Hospital Infection Therapeutics market is valued at 2700 million USD
in 2017 and is expected to reach 3490 million USD by the end of 2023, growing
at a CAGR of 4.4% between 2017 and 2023.
The Asia-Pacific will occupy for more market share in following years,
especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role
which cannot be ignored. Any changes from United States might affect the
development trend of Hospital Infection Therapeutics.
Europe also play important roles in global market, with market size of xx
million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.
Market Segment by Companies, this report covers
Bayer
Johnson & Johnson Services
Actavis
Sanofi
Bristol Myers Squibb Company
AstraZeneca
Pfizer
Merck
GlaxoSmithkline
Cubist Pharmaceuticals
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Antibacterial Drugs
Antiviral Drugs
Antifungal Drugs
Market Segment by Applications, can be divided into
Hospital Acquired Pneumonia
Surgical Site Infections
Urinary Tract Infection
Gastrointestinal Disorders
Bloodstream Infections
Others
FOR MORE
DETAILS: https://www.wiseguyreports.com/reports/3442835-global-hospital-infection-therapeutics-market-2018-by-manufacturers
About Us:
Wise Guy
Reports is part of the Wise Guy Research Consultants Pvt. Ltd. and offers
premium progressive statistical surveying, market research reports, analysis
& forecast data for industries and governments around the globe.
Contact Us:
NORAH
TRENT
Ph:
+162-825-80070
(US)
Ph: +44 203
500 2763 (UK)
Comments
Post a Comment